Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-02-003157
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 KOS PHARMACUETICALS, INC. g75180e10-k.txt 10-K 252859
3 MANAGEMENT AGREEMENT g75180ex10-24.txt EX-10.24 17875
4 MASTER SERVICES AGREEMENT g75180ex10-25.txt EX-10.25 96508
5 INVESTMENT AND ROYALTY AGREEMENT g75180ex10-26.txt EX-10.26 46776
6 WARRANT AGREEMENT g75180ex10-27.txt EX-10.27 43215
7 CONSENT OF ARTHUR ANDERDEN LLP g75180ex23.txt EX-23 454
8 LETTER RE: ARTHUR ANDERSEN LLP g75180ex99.txt EX-99 1279
  Complete submission text file 0000950144-02-003157.txt   461100
Mailing Address
Business Address 1001 BRICKELL BAY DR STE 25 MIAMI FL 33131 3055773464
KOS PHARMACEUTICALS INC (Filer) CIK: 0001018952 (see all company filings)

EIN.: 650670898 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22171 | Film No.: 02594909
SIC: 2834 Pharmaceutical Preparations